{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T19:44:13Z","timestamp":1783626253804,"version":"3.55.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,23]],"date-time":"2021-09-23T00:00:00Z","timestamp":1632355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,23]],"date-time":"2021-09-23T00:00:00Z","timestamp":1632355200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002957","name":"Technische Universit\u00e4t Dresden","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002957","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The recently developed Spine Oncology Study Group Outcomes Questionnaire (SOSGOQ2.0) was proven a valid and reliable instrument measuring health-related quality of life (HRQOL) for patients with spinal malignancies. A German version was not available.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>A cross-cultural adaptation of the SOSGOQ2.0 to the German language and its multicenter evaluation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In a multistep process, a cross-cultural adaptation of the SOSGOQ2.0 was conducted. Subsequently, a multicenter, prospective observational cohort study was initiated to assess the reliability and validity of the German adaptation. To assess external construct validity of the cross-cultural adapted questionnaire, a comparison to the established questionnaire QLQ-C30 from the European Organisation for Research and Treatment of Cancer was conducted. Mean-difference plots were used to measure the agreement between the questionnaires in total score and by domain (deviation from mean up to 10% allowed). Further reliability and validity tests were carried out. Change to baseline was analysed 3\u201316\u2009weeks later after different interventions occurred. Clinically relevant thresholds in comparison to the EORTC QLQ-C30 questionnaire were evaluated by ROC curve analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We could enroll 113 patients from four different university hospitals (58 females, 55 males). Mean age was 64.11\u2009years (sd 11.9). 80 patients had an ECOG performance status of 2 or higher at baseline. External construct validity in comparison to the EORTC QLQ-C30 questionnaire in total score and by domain was confirmed (range of deviation 4.4 to 9.0%). Good responsiveness for the domains <jats:italic>Physical Functioning<\/jats:italic> (<jats:italic>P<\/jats:italic>\u2009&lt;\u2009.001) and <jats:italic>Pain<\/jats:italic> (<jats:italic>P<\/jats:italic>\u2009&lt;\u2009.001) could be shown. The group mean values also displayed a difference in the domains of <jats:italic>Social Functioning<\/jats:italic> (<jats:italic>P<\/jats:italic>\u2009=\u2009.331) and <jats:italic>Mental Health<\/jats:italic> (<jats:italic>P<\/jats:italic>\u2009=\u2009.130), but not significant. The minimum clinically relevant threshold values for the questionnaire ranged from 4.0 to 7.5 points.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>According to our results, the cross-cultural adapted questionnaire is a reliable and valid tool to measure HRQOL in German speaking patients with spinal malignancies. Especially the domains <jats:italic>Physical Functioning<\/jats:italic> and <jats:italic>Pain<\/jats:italic> showed overall good psychometric characteristics. In this way, a generic questionnaire, such as the EORTC QLQ-C30, can be usefully supplemented by spine-specific questions to increase the overall accuracy measuring HRQOL in patients with spinal malignancies.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12885-021-08578-x","type":"journal-article","created":{"date-parts":[[2021,9,23]],"date-time":"2021-09-23T03:04:36Z","timestamp":1632366276000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["eCross-cultural adaptation of the spine oncology-specific SOSGOQ2.0 questionnaire to German language and the assessment of its validity and reliability in the clinical setting"],"prefix":"10.1186","volume":"21","author":[{"given":"T.","family":"Datzmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Kisel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Dreimann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. D.","family":"M\u00fcller-Broich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Netzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. D.","family":"Schaser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. C.","family":"Disch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Tumor Study Group, Spine Section of the German Society of Orthopaedic and Trauma Surgeons (DGOU)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. D.","family":"Schaser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. C.","family":"Disch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Dreimann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. D.","family":"M\u00fcller-Broich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Netzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Sauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Heyde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Kreinest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Arand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Liljenqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,23]]},"reference":[{"issue":"9974","key":"8578_CR1","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1016\/S0140-6736(14)61396-9","volume":"385","author":"M Quaresma","year":"2015","unstructured":"Quaresma M, Coleman MP, Rachet B. 40-year trends in an index of survival for all cancers combined and survival adjusted for age and sex for each cancer in England and Wales, 1971\u20132011: a population-based study. Lancet (London, England). 2015;385(9974):1206\u201318.","journal-title":"Lancet (London, England)"},{"issue":"5","key":"8578_CR2","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1002\/cncr.26410","volume":"118","author":"E Chow","year":"2012","unstructured":"Chow E, Nguyen J, Zhang L, Tseng LM, Hou MF, Fairchild A, et al. International field testing of the reliability and validity of the EORTC QLQ-BM22 module to assess health-related quality of life in patients with bone metastases. Cancer. 2012;118(5):1457\u201365. https:\/\/doi.org\/10.1002\/cncr.26410.","journal-title":"Cancer."},{"issue":"4","key":"8578_CR3","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1007\/s00038-002-8217-8","volume":"47","author":"BM Kurth","year":"2002","unstructured":"Kurth BM, Ellert U. The SF-36 questionnaire and its usefulness in population studies: results of the German health interview and examination survey 1998. Soz Praventivmed. 2002;47(4):266\u201377. https:\/\/doi.org\/10.1007\/s00038-002-8217-8.","journal-title":"Soz Praventivmed"},{"key":"8578_CR4","doi-asserted-by":"publisher","unstructured":"Ware JE, Jr., Sherbourne CD. The MOS 36-item short-form health survey (SF-36). Conceptual framework and item selection. Med Care. 1992;30(6):473\u201383. https:\/\/doi.org\/10.1097\/00005650-199206000-00002.","DOI":"10.1097\/00005650-199206000-00002"},{"issue":"10","key":"8578_CR5","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1016\/0277-9536(95)00112-K","volume":"41","author":"The Whoqol Group","year":"1995","unstructured":"The Whoqol Group. The World Health Organization quality of life assessment (WHOQOL): position paper from the World Health Organization. Soc Sci Med. 1995;41(10):1403\u20139.","journal-title":"Soc Sci Med"},{"key":"8578_CR6","doi-asserted-by":"crossref","unstructured":"Cella D, Tulsky D, Gg G, Sarafian B, Linn E, E B, et al. Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, Silberman M, Yellen SB, Winicour P, Brannon J. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 11(3): 570-579. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 1993;11:570\u20139.","DOI":"10.1200\/JCO.1993.11.3.570"},{"key":"8578_CR7","volume-title":"Measuring the quality of life of cancer patients with The Rotterdam Symptom Checklist (RSCL) A manual. s.n.; 1996","author":"JCJM de Haes","year":"1996","unstructured":"de Haes JCJM, Olschewski M, Fayers P, Visser MRM, Cull A, Hopwood P, et al. Measuring the quality of life of cancer patients with The Rotterdam Symptom Checklist (RSCL) A manual. s.n.; 1996 1996."},{"issue":"1","key":"8578_CR8","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/pon.2960010106","volume":"1","author":"M Watson","year":"1992","unstructured":"Watson M, Law M, Maguire GP, Robertson B, Greer S, Bliss JM, et al. Further development of a quality of life measure for cancer patients: the Rotterdam symptom checklist (revised). Psycho-Oncology. 1992;1(1):35\u201344. https:\/\/doi.org\/10.1002\/pon.2960010106.","journal-title":"Psycho-Oncology."},{"issue":"4","key":"8578_CR9","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/BF00434800","volume":"2","author":"MAG Sprangers","year":"1993","unstructured":"Sprangers MAG, Cull A, Bjordal K, Groenvold M, Aaronson NK. Life ESGoQo. The European Organization for Research and treatment of cancer approach to quality of life assessment: guidelines for developing questionnaire modules. Qual Life Res. 1993;2(4):287\u201395. https:\/\/doi.org\/10.1007\/BF00434800.","journal-title":"Qual Life Res"},{"issue":"7","key":"8578_CR10","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/j.ejca.2008.11.013","volume":"45","author":"E Chow","year":"2009","unstructured":"Chow E, Hird A, Velikova G, Johnson C, Dewolf L, Bezjak A, et al. The European Organisation for Research and Treatment of Cancer quality of life questionnaire for patients with bone metastases: the EORTC QLQ-BM22. Eur J Cancer. 2009;45(7):1146\u201352. https:\/\/doi.org\/10.1016\/j.ejca.2008.11.013.","journal-title":"Eur J Cancer"},{"issue":"2","key":"8578_CR11","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.jpainsymman.2008.08.005","volume":"38","author":"R Broom","year":"2009","unstructured":"Broom R, Du H, Clemons M, Eton D, Dranitsaris G, Simmons C, et al. Switching breast cancer patients with progressive bone metastases to third-generation bisphosphonates: measuring impact using the functional assessment of Cancer therapy-bone pain. J Pain Symptom Manag. 2009;38(2):244\u201357. https:\/\/doi.org\/10.1016\/j.jpainsymman.2008.08.005.","journal-title":"J Pain Symptom Manag"},{"issue":"2","key":"8578_CR12","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1586\/erp.11.99","volume":"12","author":"M Popovic","year":"2012","unstructured":"Popovic M, Nguyen J, Chen E, Di Giovanni J, Zeng L, Chow E. Comparison of the EORTC QLQ-BM22 and the FACT-BP for assessment of quality of life in cancer patients with bone metastases. Expert Rev Pharmacoecon Outcomes Res. 2012;12(2):213\u20139. https:\/\/doi.org\/10.1586\/erp.11.99.","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"8","key":"8578_CR13","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1002\/cncr.31240","volume":"124","author":"AL Versteeg","year":"2018","unstructured":"Versteeg AL, Sahgal A, Rhines LD, Sciubba DM, Schuster JM, Weber MH, et al. Psychometric evaluation and adaptation of the spine oncology study group outcomes questionnaire to evaluate health-related quality of life in patients with spinal metastases. Cancer. 2018;124(8):1828\u201338. https:\/\/doi.org\/10.1002\/cncr.31240.","journal-title":"Cancer."},{"issue":"14","key":"8578_CR14","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1097\/BRS.0b013e3181db96a5","volume":"35","author":"J Street","year":"2010","unstructured":"Street J, Lenehan B, Berven S, Fisher C. Introducing a new health-related quality of life outcome tool for metastatic disease of the spine: content validation using the international classification of functioning, disability, and health; on behalf of the spine oncology study group. Spine. 2010;35(14):1377\u201386. https:\/\/doi.org\/10.1097\/BRS.0b013e3181db96a5.","journal-title":"Spine."},{"issue":"24","key":"8578_CR15","doi-asserted-by":"publisher","first-page":"3186","DOI":"10.1097\/00007632-200012150-00014","volume":"25","author":"DE Beaton","year":"2000","unstructured":"Beaton DE, Bombardier C, Guillemin F, Ferraz MB. Guidelines for the process of cross-cultural adaptation of self-report measures. Spine. 2000;25(24):3186\u201391. https:\/\/doi.org\/10.1097\/00007632-200012150-00014.","journal-title":"Spine."},{"issue":"4","key":"8578_CR16","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1177\/1948550617697177","volume":"8","author":"D Lakens","year":"2017","unstructured":"Lakens D. Equivalence tests: a practical primer for t tests, correlations, and meta-analyses. Soc Psychol Personal Sci. 2017;8(4):355\u201362. https:\/\/doi.org\/10.1177\/1948550617697177.","journal-title":"Soc Psychol Personal Sci"},{"key":"8578_CR17","volume-title":"EQUIVNONINF: Testing for Equivalence and Noninferiority","author":"S Wellek","year":"2017","unstructured":"Wellek S, Ziegler P. EQUIVNONINF: Testing for Equivalence and Noninferiority; 2017."},{"key":"8578_CR18","volume-title":"R: A Language and Environment for Statistical Computing: R Foundation for Statistical Computing","author":"R Core Team","year":"2019","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing: R Foundation for Statistical Computing; 2019 [Available from: https:\/\/www.R-project.org\/."},{"key":"8578_CR19","doi-asserted-by":"publisher","DOI":"10.1017\/CBO9780511996214","volume-title":"Measurement in medicine: a practical guide","author":"HCW de Vet","year":"2011","unstructured":"de Vet HCW, Terwee CB, Mokkink LB, Knol DL. Measurement in medicine: a practical guide. Cambridge: Cambridge University Press; 2011. https:\/\/doi.org\/10.1017\/CBO9780511996214."},{"issue":"2","key":"8578_CR20","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1177\/096228029900800204","volume":"8","author":"JM Bland","year":"1999","unstructured":"Bland JM, Altman DG. Measuring agreement in method comparison studies. Stat Methods Med Res. 1999;8(2):135\u201360. https:\/\/doi.org\/10.1177\/096228029900800204.","journal-title":"Stat Methods Med Res"},{"key":"8578_CR21","doi-asserted-by":"crossref","unstructured":"Lu MJ, Zhong WH, Liu YX, Miao HZ, Li YC, Ji MH. Sample Size for Assessing Agreement between Two Methods of Measurement by Bland-Altman Method. Int J Biostat. 2016;12(2).","DOI":"10.1515\/ijb-2015-0039"},{"key":"8578_CR22","unstructured":"MedCalc Statistical Software version 18.5. (MedCalc Software bv, Ostend, Belgium; https:\/\/www.medcalc.org). 2020."},{"issue":"5","key":"8578_CR23","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S0895-4356(99)00206-1","volume":"53","author":"JA Husted","year":"2000","unstructured":"Husted JA, Cook RJ, Farewell VT, Gladman DD. Methods for assessing responsiveness: a critical review and recommendations. J Clin Epidemiol. 2000;53(5):459\u201368. https:\/\/doi.org\/10.1016\/S0895-4356(99)00206-1.","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"8578_CR24","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/j.1398-9995.2011.02719.x","volume":"67","author":"ME Schram","year":"2012","unstructured":"Schram ME, Spuls PI, Leeflang MM, Lindeboom R, Bos JD, Schmitt J. EASI, (objective) SCORAD and POEM for atopic eczema: responsiveness and minimal clinically important difference. Allergy. 2012;67(1):99\u2013106. https:\/\/doi.org\/10.1111\/j.1398-9995.2011.02719.x.","journal-title":"Allergy."},{"issue":"1","key":"8578_CR25","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12885-017-3922-0","volume":"18","author":"RK Hernandez","year":"2018","unstructured":"Hernandez RK, Wade SW, Reich A, Pirolli M, Liede A, Lyman GH. Incidence of bone metastases in patients with solid tumors: analysis of oncology electronic medical records in the United States. BMC Cancer. 2018;18(1):44. https:\/\/doi.org\/10.1186\/s12885-017-3922-0.","journal-title":"BMC Cancer"},{"issue":"3","key":"8578_CR26","first-page":"348","volume":"4","author":"HR Jocham","year":"2009","unstructured":"Jocham HR, Dassen T, Widdershoven G, Halfens R. Reliability and validity of the EORTC QLQ-C30 in palliative care cancer patients. Central Eur J Med. 2009;4(3):348\u201357.","journal-title":"Central Eur J Med"},{"issue":"1","key":"8578_CR27","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ejso.2019.08.019","volume":"46","author":"AC Disch","year":"2020","unstructured":"Disch AC, Kleber C, Redemann D, Druschel C, Liljenqvist U, Schaser KD. Current surgical strategies for treating spinal tumors: results of a questionnaire survey among members of the German spine society (DWG). Eur J Surg Oncol. 2020;46(1):89\u201394. https:\/\/doi.org\/10.1016\/j.ejso.2019.08.019.","journal-title":"Eur J Surg Oncol"},{"key":"8578_CR28","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/978-3-540-77960-5_10","volume":"179","author":"KD Schaser","year":"2009","unstructured":"Schaser KD, Melcher I, Luzzati A, Disch AC. Bone sarcoma of the spine. Recent Results Cancer Res. 2009;179:141\u201367. https:\/\/doi.org\/10.1007\/978-3-540-77960-5_10.","journal-title":"Recent Results Cancer Res"},{"issue":"Suppl 20","key":"8578_CR29","doi-asserted-by":"publisher","first-page":"S212","DOI":"10.1097\/BRS.0000000000001821","volume":"41","author":"N Dea","year":"2016","unstructured":"Dea N, Charest-Morin R, Sciubba DM, Bird JE, Disch AC, Mesfin A, et al. Optimizing the adverse event and HRQOL profiles in the Management of Primary Spine Tumors. Spine. 2016;41(Suppl 20):S212\u2013s7. https:\/\/doi.org\/10.1097\/BRS.0000000000001821.","journal-title":"Spine."},{"issue":"12","key":"8578_CR30","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.1016\/j.spinee.2014.03.043","volume":"14","author":"M Huisman","year":"2014","unstructured":"Huisman M, van der Velden JM, van Vulpen M, van den Bosch MA, Chow E, \u00d6ner FC, et al. Spinal instability as defined by the spinal instability neoplastic score is associated with radiotherapy failure in metastatic spinal disease. Spine J. 2014;14(12):2835\u201340. https:\/\/doi.org\/10.1016\/j.spinee.2014.03.043.","journal-title":"Spine J"},{"issue":"1","key":"8578_CR31","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1634\/theoncologist.2015-0266","volume":"21","author":"AL Versteeg","year":"2016","unstructured":"Versteeg AL, van der Velden JM, Verkooijen HM, van Vulpen M, Oner FC, Fisher CG, et al. The effect of introducing the spinal instability neoplastic score in routine clinical practice for patients with spinal metastases. Oncologist. 2016;21(1):95\u2013101. https:\/\/doi.org\/10.1634\/theoncologist.2015-0266.","journal-title":"Oncologist."},{"issue":"2","key":"8578_CR32","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1037\/a0036834","volume":"70","author":"VF Reyna","year":"2015","unstructured":"Reyna VF, Nelson WL, Han PK, Pignone MP. Decision making and cancer. Am Psychol. 2015;70(2):105\u201318. https:\/\/doi.org\/10.1037\/a0036834.","journal-title":"Am Psychol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-08578-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-021-08578-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-08578-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,23]],"date-time":"2021-09-23T03:04:56Z","timestamp":1632366296000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-021-08578-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,23]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["8578"],"URL":"https:\/\/doi.org\/10.1186\/s12885-021-08578-x","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,23]]},"assertion":[{"value":"12 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"A separate ethics vote at all four participating sites was obtained in advance (EK33012019, EK19\u2013482, MC323\/19, and EKNZ2020\u201300367). Written informed consent was obtained from all study participants before enrollment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Data were presented in aggregate form only. Conclusions about individual persons are therefore not possible.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"ACD reports: AO Spine Knowledge Forum. Funding for MTRON + PTRON study. JS reports grants from Sanofi, Pfizer, Novatris, personal fees from Sanofi, Lilly, Novartis, outside the submitted work. The other authors have nothing to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1044"}}